Leon Struett

Leon is a Director at Deloitte specialising in the Life Sciences sector. With over 12 years of experience, he advises clients at the critical intersection of commercial and market access, driving successful launch of new innovative therapies across global markets. His extensive experience spans early value shaping, evidence generation, and strategic navigation of Health Technology Assessment (HTA) regulatory compliance as well as commercial Go-to-Market models and brand strategy.

Leon has a critical role in advancing next-generation Market Access capabilities, having helped organisations design and implement market-leading operating models that address increasing complexity and payer expectations. He leads Deloitte Switzerland’s Market Access community as well as Deloitte’s EU HTA advisory, collaborating with key stakeholders at the forefront of regulatory and access strategy in Europe and beyond.